Literature DB >> 26416243

Long-Term Administration of High-Fat Diet Corrects Abnormal Bone Remodeling in the Tibiae of Interleukin-6-Deficient Mice.

Wei Feng1, Bo Liu1, Di Liu1, Tomoka Hasegawa2, Wei Wang1, Xiuchun Han1, Jian Cui1, Kimimitsu Oda3, Norio Amizuka2, Minqi Li1.   

Abstract

In this study, we aimed to evaluate the influence of diet-induced obesity on IL-6 deficiency-induced bone remodeling abnormality. Seven-week-old IL-6(-/-) mice and their wild type (WT) littermates were fed a standard diet (SD) or high-fat diet (HFD) for 25 weeks. Lipid formation and bone metabolism in mice tibiae were investigated by histochemical analysis. Both IL-6(-/-) and WT mice fed the HFD showed notable body weight gain, thickened cortical bones, and adipose accumulation in the bone marrow. Notably, the HFD normalized the bone phenotype of IL-6(-/-) mice to that of their WT counterpart, as characterized by a decrease in bone mass and the presence of an obliquely arranged, plate-like morphology in the trabecular bone. Alkaline phosphatase and osteocalcin expressions were attenuated in both genotypes after HFD feeding, especially for the IL-6(-/-) mice. Meanwhile, tartrate-resistant acid phosphatase staining was inhibited, osteoclast apoptosis rate down-regulated (revealed by TUNEL assay), and the proportion of cathepsin K (CK)-positive osteoclasts significantly increased in IL-6(-/-) mice on a HFD as compared with IL-6(-/-) mice on standard chow. Our results demonstrate that HFD-induced obesity reverses IL-6 deficiency-associated bone metabolic disorders by suppressing osteoblast activity, upregulating osteoclastic activity, and inhibiting osteoclast apoptosis.
© The Author(s) 2015.

Entities:  

Keywords:  IL-6; bone metabolism; obesity; osteoblast; osteoclast

Mesh:

Substances:

Year:  2015        PMID: 26416243      PMCID: PMC4810790          DOI: 10.1369/0022155415611931

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  54 in total

Review 1.  Interleukin-6: An osteotropic factor influencing bone formation?

Authors:  Nathalie Franchimont; Sylvie Wertz; Michel Malaise
Journal:  Bone       Date:  2005-08-19       Impact factor: 4.398

2.  The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.

Authors:  Kimihiko Sawakami; Alexander G Robling; Minrong Ai; Nathaniel D Pitner; Dawei Liu; Stuart J Warden; Jiliang Li; Peter Maye; David W Rowe; Randall L Duncan; Matthew L Warman; Charles H Turner
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

Review 3.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

4.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

5.  Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Authors:  P Ravn; G Cizza; N H Bjarnason; D Thompson; M Daley; R D Wasnich; M McClung; D Hosking; A J Yates; C Christiansen
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

6.  Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo.

Authors:  Kazuhiro Yokota; Kojiro Sato; Takashi Miyazaki; Hideki Kitaura; Hisako Kayama; Fumihiko Miyoshi; Yasuto Araki; Yuji Akiyama; Kiyoshi Takeda; Toshihide Mimura
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

7.  Effects of recombinant human interleukin-6 administration on bone in rhesus monkeys.

Authors:  N C Binkley; W H Sun; M M Checovich; E B Roecker; D B Kimmel; W B Ershler
Journal:  Lymphokine Cytokine Res       Date:  1994-08

8.  Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

Authors:  Laurence Duplomb; Marc Baud'huin; Céline Charrier; Martine Berreur; Valérie Trichet; Frédéric Blanchard; Dominique Heymann
Journal:  Endocrinology       Date:  2008-04-10       Impact factor: 4.736

9.  Adiponectin exerts its negative effect on bone metabolism via OPG/RANKL pathway: an in vivo study.

Authors:  Qing-Ping Wang; Xian-Ping Li; Min Wang; Li-Ling Zhao; Hui Li; Hui Xie; Zhi-Yong Lu
Journal:  Endocrine       Date:  2014-03-14       Impact factor: 3.633

Review 10.  Osteoporosis and inflammation.

Authors:  Gregory R Mundy
Journal:  Nutr Rev       Date:  2007-12       Impact factor: 7.110

View more
  4 in total

Review 1.  The Impact of Diet on Bone and Fracture Risk in Diabetes.

Authors:  M Faraj; N Napoli
Journal:  Curr Osteoporos Rep       Date:  2022-02-24       Impact factor: 5.096

Review 2.  Impact of Chronic Inflammation in Psoriasis on Bone Metabolism.

Authors:  Anja Saalbach; Manfred Kunz
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

3.  Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway.

Authors:  Cancan Huang; Chaotao Zhang; Panpan Yang; Rui Chao; Ziqi Yue; Congshan Li; Jie Guo; Minqi Li
Journal:  Drug Des Devel Ther       Date:  2020-11-13       Impact factor: 4.162

4.  Interleukin-6 Knockout Inhibits Senescence of Bone Mesenchymal Stem Cells in High-Fat Diet-Induced Bone Loss.

Authors:  Yujue Li; Lingyun Lu; Ying Xie; Xiang Chen; Li Tian; Yan Liang; Huifang Li; Jie Zhang; Yi Liu; Xijie Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-19       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.